Welcome to Lawsuit.com  

Our mission is to provide each client with the most effective ethical representation possible, and to preserve and promote the civil justice system.

Market Withdrawal of Zelnorm

Posted on April 29, 2008

Novartis Pharmaceuticals has agreed to stop selling Zelnorm because of safety concerns. Zelnorm (tegaserod maleate) had been approved to treat certain patients with irritable bowel syndrome and chronic constipation.

Zelnorm was taken off the market because a new analysis of 29 studies showed that taking this drug increased the risk of serious cardiovascular adverse events. Because of this, FDA believes that the benefits of the drug no longer outweigh the risks.

Patients being treated with Zelnorm should contact their doctors to discuss alternative treatments.

Prescribers should work with their patients to find other appropriate therapies. There may be some patients, however, with no other treatment options where the benefits of Zelnorm outweigh the risks. These patients may continue to receive Zelnorm if necessary through a special program that FDA has established with Novartis. Physicians can apply to the FDA for permission to prescribe Zelnorm for a patient through what's called an "Emergency IND."

Additional Information:

FDA MedWatch Safety Alert. Zelnorm (tegaserod maleate). March 30, 2007.
http://www.fda.gov/medwatch/safety/2007/safety07.htm#Zelnorm

FDA Center for Drug Evaluation and Research. Questions and Answers on Zelnorm (tegaserod maleate). March 30, 2007.
http://www.fda.gov/cder/drug/infopage/zelnorm/zelnorm_QA_2007.htm

Lawsuit Membership
Law firms interested in becoming part of this unique legal community should apply here.Join Lawsuit.com

Lawsuit Video Tips
To become a participating member of Lawsuit.com you must supply a video about your firm, talk about the litigation you find important, and how you help your clients. For ideas and video tips on effective videos click here. Video Creation Tips

Become an Editor
Lawsuit.com is currently building one of the largest human-edited legal video databases in the Web 2.0 World. Want to help? Apply here to become an Editor.Comment